Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global Transcutaneous Bilirubin Meters Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Transcutaneous Bilirubin Meters Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Medical Devices & Consumables
Published Date: 2025-11-02
Pages: 175 Pages
Report ld: 5344298
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Transcutaneous Bilirubin Meters Market Size(US$)
CAGR 2025-2031
2.8%
Market Size,2031
USD 122
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 103 million
Market Forecast in 2031(Value)
US$ 122 million
CAGR
2.8%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Transcutaneous Bilirubin Meters market is projected to grow from US$ 101 million in 2024 to US$ 122 million by 2031, at a CAGR of 2.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
A transcutaneous bilirubin meters is a device that measures the yellowish pigmentation of the skin and other mucous membranes caused by hyperbilirubinemia (increased levels of bilirubin in the blood). They are widely used in children"s hospitals, baby care centers all over the world.
Transcutaneous Bilirubin Meters market driver as below：
Neonatal Jaundice Management: Transcutaneous bilirubin meters offer a non-invasive and convenient way to monitor bilirubin levels in newborns, especially those at risk of developing neonatal jaundice. Early detection and management of jaundice are critical to prevent complications.
Avoiding Invasive Procedures: Traditional methods of measuring bilirubin levels involve blood tests, which can be uncomfortable for newborns. Transcutaneous bilirubin meters eliminate the need for blood sampling, reducing discomfort and stress for infants and their families.
Preventing Kernicterus: Monitoring bilirubin levels helps prevent kernicterus, a serious condition that can result from untreated severe jaundice and lead to neurological damage in infants.
Home Monitoring: Some transcutaneous bilirubin meters are designed for use at home, allowing parents and caregivers to monitor bilirubin levels and seek medical attention if necessary.
Telemedicine and Remote Care: The integration of transcutaneous bilirubin meters with telemedicine platforms enables healthcare providers to remotely monitor neonatal patients and provide timely guidance to caregivers.
Global Increase in Birth Rates: As the global birth rate increases, the demand for effective neonatal care equipment, including transcutaneous bilirubin meters, is expected to rise.
Healthcare Accessibility: In regions with limited access to healthcare facilities, portable transcutaneous bilirubin meters can provide a valuable tool for assessing neonatal health.
Technological Advancements: Ongoing advancements in sensor technology, data analysis algorithms, and device design contribute to the development of more accurate and user-friendly transcutaneous bilirubin meters.
Regulatory Approval: As transcutaneous bilirubin meters receive regulatory approvals and certifications, they gain credibility and acceptance in the medical community.
Focus on Preventive Care: Healthcare systems emphasize preventive care, and transcutaneous bilirubin meters play a role in detecting and managing conditions before they escalate.
Quality of Care: Accurate and reliable transcutaneous bilirubin measurements contribute to providing high-quality care to newborns and infants.
Cost-Effectiveness: Non-invasive measurements with transcutaneous bilirubin meters can lead to cost savings by reducing the need for repeated blood tests.
Education and Training: Healthcare providers are trained to use transcutaneous bilirubin meters effectively, ensuring accurate measurements and proper interpretation of results.
Research and Guidelines: Evidence-based research and clinical guidelines promote the use of transcutaneous bilirubin meters as a reliable method for bilirubin level assessment.
Global Health Initiatives: International health organizations and initiatives may prioritize the availability of essential neonatal care equipment, including transcutaneous bilirubin meters.
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Transcutaneous Bilirubin Meters market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region's dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Delta Medical International
- Dräger
- Philips
- Natus Medical
- Refine Medical Technology
- Aegis Medical Innovations
- Mennen Medical
- Medi Waves
- ICLEAR HEALTHCARE
- AVI Healthcare
- Micro Lab
- Ningbo David Medical Device
- Beijing M&B Electronic Instruments
- NISON INSTRUMENT (SHANGHAI) LIMITED
- Xuzhou Kejian Hi-tech
- Zhengzhou Dison Instrument And Meter
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Portable Type
- Desktop Type
Segment by Application
- Hospitals
- Clinics
- Ambulatory Surgical Centers
CHAPTER OUTLINE
Chapter 1: Defines the Transcutaneous Bilirubin Meters study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Transcutaneous Bilirubin Meters: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Transcutaneous Bilirubin Meters Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Portable Type
1.2.3 Desktop Type
1.3 Market Segmentation by Application
1.3.1 Global Transcutaneous Bilirubin Meters Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Transcutaneous Bilirubin Meters Revenue Estimates and Forecasts 2020-2031
2.2 Global Transcutaneous Bilirubin Meters Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Transcutaneous Bilirubin Meters Sales Estimates and Forecasts 2020-2031
2.4 Global Transcutaneous Bilirubin Meters Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Transcutaneous Bilirubin Meters Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Transcutaneous Bilirubin Meters Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Portable Type Market Size by Manufacturers
3.5.2 Desktop Type Market Size by Manufacturers
3.6 Global Transcutaneous Bilirubin Meters Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Transcutaneous Bilirubin Meters Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Transcutaneous Bilirubin Meters Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Transcutaneous Bilirubin Meters Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Transcutaneous Bilirubin Meters Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Transcutaneous Bilirubin Meters Sales and Revenue by Type (2020-2031)
6.4 North America Transcutaneous Bilirubin Meters Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Transcutaneous Bilirubin Meters Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Transcutaneous Bilirubin Meters Sales and Revenue by Type (2020-2031)
7.4 Europe Transcutaneous Bilirubin Meters Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Transcutaneous Bilirubin Meters Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Transcutaneous Bilirubin Meters Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Transcutaneous Bilirubin Meters Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Transcutaneous Bilirubin Meters Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Transcutaneous Bilirubin Meters Sales and Revenue by Type (2020-2031)
9.4 Central and South America Transcutaneous Bilirubin Meters Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Transcutaneous Bilirubin Meters Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Transcutaneous Bilirubin Meters Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Transcutaneous Bilirubin Meters Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Transcutaneous Bilirubin Meters Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Delta Medical International
11.1.1 Delta Medical International Corporation Information
11.1.2 Delta Medical International Business Overview
11.1.3 Delta Medical International Transcutaneous Bilirubin Meters Product Models, Descriptions and Specifications
11.1.4 Delta Medical International Transcutaneous Bilirubin Meters Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Delta Medical International Transcutaneous Bilirubin Meters Sales by Product in 2024
11.1.6 Delta Medical International Transcutaneous Bilirubin Meters Sales by Application in 2024
11.1.7 Delta Medical International Transcutaneous Bilirubin Meters Sales by Geographic Area in 2024
11.1.8 Delta Medical International Transcutaneous Bilirubin Meters SWOT Analysis
11.1.9 Delta Medical International Recent Developments
11.2 Dräger
11.2.1 Dräger Corporation Information
11.2.2 Dräger Business Overview
11.2.3 Dräger Transcutaneous Bilirubin Meters Product Models, Descriptions and Specifications
11.2.4 Dräger Transcutaneous Bilirubin Meters Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Dräger Transcutaneous Bilirubin Meters Sales by Product in 2024
11.2.6 Dräger Transcutaneous Bilirubin Meters Sales by Application in 2024
11.2.7 Dräger Transcutaneous Bilirubin Meters Sales by Geographic Area in 2024
11.2.8 Dräger Transcutaneous Bilirubin Meters SWOT Analysis
11.2.9 Dräger Recent Developments
11.3 Philips
11.3.1 Philips Corporation Information
11.3.2 Philips Business Overview
11.3.3 Philips Transcutaneous Bilirubin Meters Product Models, Descriptions and Specifications
11.3.4 Philips Transcutaneous Bilirubin Meters Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Philips Transcutaneous Bilirubin Meters Sales by Product in 2024
11.3.6 Philips Transcutaneous Bilirubin Meters Sales by Application in 2024
11.3.7 Philips Transcutaneous Bilirubin Meters Sales by Geographic Area in 2024
11.3.8 Philips Transcutaneous Bilirubin Meters SWOT Analysis
11.3.9 Philips Recent Developments
11.4 Natus Medical
11.4.1 Natus Medical Corporation Information
11.4.2 Natus Medical Business Overview
11.4.3 Natus Medical Transcutaneous Bilirubin Meters Product Models, Descriptions and Specifications
11.4.4 Natus Medical Transcutaneous Bilirubin Meters Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Natus Medical Transcutaneous Bilirubin Meters Sales by Product in 2024
11.4.6 Natus Medical Transcutaneous Bilirubin Meters Sales by Application in 2024
11.4.7 Natus Medical Transcutaneous Bilirubin Meters Sales by Geographic Area in 2024
11.4.8 Natus Medical Transcutaneous Bilirubin Meters SWOT Analysis
11.4.9 Natus Medical Recent Developments
11.5 Refine Medical Technology
11.5.1 Refine Medical Technology Corporation Information
11.5.2 Refine Medical Technology Business Overview
11.5.3 Refine Medical Technology Transcutaneous Bilirubin Meters Product Models, Descriptions and Specifications
11.5.4 Refine Medical Technology Transcutaneous Bilirubin Meters Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Refine Medical Technology Transcutaneous Bilirubin Meters Sales by Product in 2024
11.5.6 Refine Medical Technology Transcutaneous Bilirubin Meters Sales by Application in 2024
11.5.7 Refine Medical Technology Transcutaneous Bilirubin Meters Sales by Geographic Area in 2024
11.5.8 Refine Medical Technology Transcutaneous Bilirubin Meters SWOT Analysis
11.5.9 Refine Medical Technology Recent Developments
11.6 Aegis Medical Innovations
11.6.1 Aegis Medical Innovations Corporation Information
11.6.2 Aegis Medical Innovations Business Overview
11.6.3 Aegis Medical Innovations Transcutaneous Bilirubin Meters Product Models, Descriptions and Specifications
11.6.4 Aegis Medical Innovations Transcutaneous Bilirubin Meters Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Aegis Medical Innovations Recent Developments
11.7 Mennen Medical
11.7.1 Mennen Medical Corporation Information
11.7.2 Mennen Medical Business Overview
11.7.3 Mennen Medical Transcutaneous Bilirubin Meters Product Models, Descriptions and Specifications
11.7.4 Mennen Medical Transcutaneous Bilirubin Meters Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Mennen Medical Recent Developments
11.8 Medi Waves
11.8.1 Medi Waves Corporation Information
11.8.2 Medi Waves Business Overview
11.8.3 Medi Waves Transcutaneous Bilirubin Meters Product Models, Descriptions and Specifications
11.8.4 Medi Waves Transcutaneous Bilirubin Meters Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Medi Waves Recent Developments
11.9 ICLEAR HEALTHCARE
11.9.1 ICLEAR HEALTHCARE Corporation Information
11.9.2 ICLEAR HEALTHCARE Business Overview
11.9.3 ICLEAR HEALTHCARE Transcutaneous Bilirubin Meters Product Models, Descriptions and Specifications
11.9.4 ICLEAR HEALTHCARE Transcutaneous Bilirubin Meters Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 ICLEAR HEALTHCARE Recent Developments
11.10 AVI Healthcare
11.10.1 AVI Healthcare Corporation Information
11.10.2 AVI Healthcare Business Overview
11.10.3 AVI Healthcare Transcutaneous Bilirubin Meters Product Models, Descriptions and Specifications
11.10.4 AVI Healthcare Transcutaneous Bilirubin Meters Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 AVI Healthcare Recent Developments
11.11 Micro Lab
11.11.1 Micro Lab Corporation Information
11.11.2 Micro Lab Business Overview
11.11.3 Micro Lab Transcutaneous Bilirubin Meters Product Models, Descriptions and Specifications
11.11.4 Micro Lab Transcutaneous Bilirubin Meters Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Micro Lab Recent Developments
11.12 Ningbo David Medical Device
11.12.1 Ningbo David Medical Device Corporation Information
11.12.2 Ningbo David Medical Device Business Overview
11.12.3 Ningbo David Medical Device Transcutaneous Bilirubin Meters Product Models, Descriptions and Specifications
11.12.4 Ningbo David Medical Device Transcutaneous Bilirubin Meters Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 Ningbo David Medical Device Recent Developments
11.13 Beijing M&B Electronic Instruments
11.13.1 Beijing M&B Electronic Instruments Corporation Information
11.13.2 Beijing M&B Electronic Instruments Business Overview
11.13.3 Beijing M&B Electronic Instruments Transcutaneous Bilirubin Meters Product Models, Descriptions and Specifications
11.13.4 Beijing M&B Electronic Instruments Transcutaneous Bilirubin Meters Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 Beijing M&B Electronic Instruments Recent Developments
11.14 NISON INSTRUMENT (SHANGHAI) LIMITED
11.14.1 NISON INSTRUMENT (SHANGHAI) LIMITED Corporation Information
11.14.2 NISON INSTRUMENT (SHANGHAI) LIMITED Business Overview
11.14.3 NISON INSTRUMENT (SHANGHAI) LIMITED Transcutaneous Bilirubin Meters Product Models, Descriptions and Specifications
11.14.4 NISON INSTRUMENT (SHANGHAI) LIMITED Transcutaneous Bilirubin Meters Sales, Price, Revenue and Gross Margin (2020-2025)
11.14.5 NISON INSTRUMENT (SHANGHAI) LIMITED Recent Developments
11.15 Xuzhou Kejian Hi-tech
11.15.1 Xuzhou Kejian Hi-tech Corporation Information
11.15.2 Xuzhou Kejian Hi-tech Business Overview
11.15.3 Xuzhou Kejian Hi-tech Transcutaneous Bilirubin Meters Product Models, Descriptions and Specifications
11.15.4 Xuzhou Kejian Hi-tech Transcutaneous Bilirubin Meters Sales, Price, Revenue and Gross Margin (2020-2025)
11.15.5 Xuzhou Kejian Hi-tech Recent Developments
11.16 Zhengzhou Dison Instrument And Meter
11.16.1 Zhengzhou Dison Instrument And Meter Corporation Information
11.16.2 Zhengzhou Dison Instrument And Meter Business Overview
11.16.3 Zhengzhou Dison Instrument And Meter Transcutaneous Bilirubin Meters Product Models, Descriptions and Specifications
11.16.4 Zhengzhou Dison Instrument And Meter Transcutaneous Bilirubin Meters Sales, Price, Revenue and Gross Margin (2020-2025)
11.16.5 Zhengzhou Dison Instrument And Meter Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Transcutaneous Bilirubin Meters Industry Chain
12.2 Transcutaneous Bilirubin Meters Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Transcutaneous Bilirubin Meters Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Transcutaneous Bilirubin Meters Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Transcutaneous Bilirubin Meters Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Transcutaneous Bilirubin Meters Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Transcutaneous Bilirubin Meters Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Transcutaneous Bilirubin Meters Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Transcutaneous Bilirubin Meters Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Transcutaneous Bilirubin Meters Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Transcutaneous Bilirubin Meters Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Transcutaneous Bilirubin Meters Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Transcutaneous Bilirubin Meters Sales by Region (2020-2025) & (K Units)
Table 8. Global Transcutaneous Bilirubin Meters Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Transcutaneous Bilirubin Meters Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Transcutaneous Bilirubin Meters Sales Share by Manufacturers (2020-2025)
Table 12. Global Transcutaneous Bilirubin Meters Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Transcutaneous Bilirubin Meters Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Transcutaneous Bilirubin Meters by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transcutaneous Bilirubin Meters as of 2024)
Table 16. Global Transcutaneous Bilirubin Meters Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Transcutaneous Bilirubin Meters Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Transcutaneous Bilirubin Meters Manufacturing Base and Headquarters
Table 19. Global Transcutaneous Bilirubin Meters Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Transcutaneous Bilirubin Meters Sales by Type (2020-2025) & (K Units)
Table 23. Global Transcutaneous Bilirubin Meters Sales by Type (2026-2031) & (K Units)
Table 24. Global Transcutaneous Bilirubin Meters Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Transcutaneous Bilirubin Meters Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Transcutaneous Bilirubin Meters ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Transcutaneous Bilirubin Meters Sales by Application (2020-2025) & (K Units)
Table 29. Global Transcutaneous Bilirubin Meters Sales by Application (2026-2031) & (K Units)
Table 30. Transcutaneous Bilirubin Meters High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Transcutaneous Bilirubin Meters Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Transcutaneous Bilirubin Meters Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Transcutaneous Bilirubin Meters ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Transcutaneous Bilirubin Meters Growth Accelerators and Market Barriers
Table 37. North America Transcutaneous Bilirubin Meters Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Transcutaneous Bilirubin Meters Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Transcutaneous Bilirubin Meters Growth Accelerators and Market Barriers
Table 40. Europe Transcutaneous Bilirubin Meters Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Transcutaneous Bilirubin Meters Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Transcutaneous Bilirubin Meters Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Transcutaneous Bilirubin Meters Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Transcutaneous Bilirubin Meters Growth Accelerators and Market Barriers
Table 45. Southeast Asia Transcutaneous Bilirubin Meters Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Transcutaneous Bilirubin Meters Investment Opportunities and Key Challenges
Table 47. Central and South America Transcutaneous Bilirubin Meters Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Transcutaneous Bilirubin Meters Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Transcutaneous Bilirubin Meters Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Delta Medical International Corporation Information
Table 51. Delta Medical International Description and Major Businesses
Table 52. Delta Medical International Product Models, Descriptions and Specifications
Table 53. Delta Medical International Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Delta Medical International Sales Value Proportion by Product in 2024
Table 55. Delta Medical International Sales Value Proportion by Application in 2024
Table 56. Delta Medical International Sales Value Proportion by Geographic Area in 2024
Table 57. Delta Medical International Transcutaneous Bilirubin Meters SWOT Analysis
Table 58. Delta Medical International Recent Developments
Table 59. Dräger Corporation Information
Table 60. Dräger Description and Major Businesses
Table 61. Dräger Product Models, Descriptions and Specifications
Table 62. Dräger Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. Dräger Sales Value Proportion by Product in 2024
Table 64. Dräger Sales Value Proportion by Application in 2024
Table 65. Dräger Sales Value Proportion by Geographic Area in 2024
Table 66. Dräger Transcutaneous Bilirubin Meters SWOT Analysis
Table 67. Dräger Recent Developments
Table 68. Philips Corporation Information
Table 69. Philips Description and Major Businesses
Table 70. Philips Product Models, Descriptions and Specifications
Table 71. Philips Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Philips Sales Value Proportion by Product in 2024
Table 73. Philips Sales Value Proportion by Application in 2024
Table 74. Philips Sales Value Proportion by Geographic Area in 2024
Table 75. Philips Transcutaneous Bilirubin Meters SWOT Analysis
Table 76. Philips Recent Developments
Table 77. Natus Medical Corporation Information
Table 78. Natus Medical Description and Major Businesses
Table 79. Natus Medical Product Models, Descriptions and Specifications
Table 80. Natus Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Natus Medical Sales Value Proportion by Product in 2024
Table 82. Natus Medical Sales Value Proportion by Application in 2024
Table 83. Natus Medical Sales Value Proportion by Geographic Area in 2024
Table 84. Natus Medical Transcutaneous Bilirubin Meters SWOT Analysis
Table 85. Natus Medical Recent Developments
Table 86. Refine Medical Technology Corporation Information
Table 87. Refine Medical Technology Description and Major Businesses
Table 88. Refine Medical Technology Product Models, Descriptions and Specifications
Table 89. Refine Medical Technology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Refine Medical Technology Sales Value Proportion by Product in 2024
Table 91. Refine Medical Technology Sales Value Proportion by Application in 2024
Table 92. Refine Medical Technology Sales Value Proportion by Geographic Area in 2024
Table 93. Refine Medical Technology Transcutaneous Bilirubin Meters SWOT Analysis
Table 94. Refine Medical Technology Recent Developments
Table 95. Aegis Medical Innovations Corporation Information
Table 96. Aegis Medical Innovations Description and Major Businesses
Table 97. Aegis Medical Innovations Product Models, Descriptions and Specifications
Table 98. Aegis Medical Innovations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Aegis Medical Innovations Recent Developments
Table 100. Mennen Medical Corporation Information
Table 101. Mennen Medical Description and Major Businesses
Table 102. Mennen Medical Product Models, Descriptions and Specifications
Table 103. Mennen Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Mennen Medical Recent Developments
Table 105. Medi Waves Corporation Information
Table 106. Medi Waves Description and Major Businesses
Table 107. Medi Waves Product Models, Descriptions and Specifications
Table 108. Medi Waves Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. Medi Waves Recent Developments
Table 110. ICLEAR HEALTHCARE Corporation Information
Table 111. ICLEAR HEALTHCARE Description and Major Businesses
Table 112. ICLEAR HEALTHCARE Product Models, Descriptions and Specifications
Table 113. ICLEAR HEALTHCARE Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. ICLEAR HEALTHCARE Recent Developments
Table 115. AVI Healthcare Corporation Information
Table 116. AVI Healthcare Description and Major Businesses
Table 117. AVI Healthcare Product Models, Descriptions and Specifications
Table 118. AVI Healthcare Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. AVI Healthcare Recent Developments
Table 120. Micro Lab Corporation Information
Table 121. Micro Lab Description and Major Businesses
Table 122. Micro Lab Product Models, Descriptions and Specifications
Table 123. Micro Lab Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 124. Micro Lab Recent Developments
Table 125. Ningbo David Medical Device Corporation Information
Table 126. Ningbo David Medical Device Description and Major Businesses
Table 127. Ningbo David Medical Device Product Models, Descriptions and Specifications
Table 128. Ningbo David Medical Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 129. Ningbo David Medical Device Recent Developments
Table 130. Beijing M&B Electronic Instruments Corporation Information
Table 131. Beijing M&B Electronic Instruments Description and Major Businesses
Table 132. Beijing M&B Electronic Instruments Product Models, Descriptions and Specifications
Table 133. Beijing M&B Electronic Instruments Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 134. Beijing M&B Electronic Instruments Recent Developments
Table 135. NISON INSTRUMENT (SHANGHAI) LIMITED Corporation Information
Table 136. NISON INSTRUMENT (SHANGHAI) LIMITED Description and Major Businesses
Table 137. NISON INSTRUMENT (SHANGHAI) LIMITED Product Models, Descriptions and Specifications
Table 138. NISON INSTRUMENT (SHANGHAI) LIMITED Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 139. NISON INSTRUMENT (SHANGHAI) LIMITED Recent Developments
Table 140. Xuzhou Kejian Hi-tech Corporation Information
Table 141. Xuzhou Kejian Hi-tech Description and Major Businesses
Table 142. Xuzhou Kejian Hi-tech Product Models, Descriptions and Specifications
Table 143. Xuzhou Kejian Hi-tech Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 144. Xuzhou Kejian Hi-tech Recent Developments
Table 145. Zhengzhou Dison Instrument And Meter Corporation Information
Table 146. Zhengzhou Dison Instrument And Meter Description and Major Businesses
Table 147. Zhengzhou Dison Instrument And Meter Product Models, Descriptions and Specifications
Table 148. Zhengzhou Dison Instrument And Meter Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 149. Zhengzhou Dison Instrument And Meter Recent Developments
Table 150. Key Raw Materials Distribution
Table 151. Raw Materials Key Suppliers
Table 152. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 153. Milestones in Production Technology Evolution
Table 154. Distributors List
Table 155. Market Trends and Market Evolution
Table 156. Market Drivers and Opportunities
Table 157. Market Challenges, Risks, and Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Transcutaneous Bilirubin Meters Product Picture
Figure 2. Global Transcutaneous Bilirubin Meters Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Portable Type Product Picture
Figure 4. Desktop Type Product Picture
Figure 5. Global Transcutaneous Bilirubin Meters Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Hospitals
Figure 7. Clinics
Figure 8. Ambulatory Surgical Centers
Figure 9. Transcutaneous Bilirubin Meters Report Years Considered
Figure 10. Global Transcutaneous Bilirubin Meters Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Transcutaneous Bilirubin Meters Revenue (2020-2031) & (US$ Million)
Figure 12. Global Transcutaneous Bilirubin Meters Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 13. Global Transcutaneous Bilirubin Meters Revenue Market Share by Region (2020-2031)
Figure 14. Global Transcutaneous Bilirubin Meters Sales (2020-2031) & (K Units)
Figure 15. Global Transcutaneous Bilirubin Meters Sales (CAGR) by Region (2020-2031) (K Units)
Figure 16. Global Transcutaneous Bilirubin Meters Sales Market Share by Region (2020-2031)
Figure 17. Top 5 and Top 10 Manufacturers Transcutaneous Bilirubin Meters Sales Volume Market Share in 2024
Figure 18. Global Transcutaneous Bilirubin Meters Revenue Market Share Ranking (2024)
Figure 19. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 20. Portable Type Revenue Market Share by Manufacturer in 2024
Figure 21. Desktop Type Revenue Market Share by Manufacturer in 2024
Figure 22. Global Transcutaneous Bilirubin Meters Sales Market Share by Type (2020-2031)
Figure 23. Global Transcutaneous Bilirubin Meters Revenue Market Share by Type (2020-2031)
Figure 24. Global Transcutaneous Bilirubin Meters Sales Market Share by Application (2020-2031)
Figure 25. Global Transcutaneous Bilirubin Meters Revenue Market Share by Application (2020-2031)
Figure 26. North America Transcutaneous Bilirubin Meters Sales YoY (2020-2031) & (K Units)
Figure 27. North America Transcutaneous Bilirubin Meters Revenue YoY (2020-2031) & (US$ Million)
Figure 28. North America Top 5 Manufacturers Transcutaneous Bilirubin Meters Sales Revenue (US$ Million) in 2024
Figure 29. North America Transcutaneous Bilirubin Meters Sales Volume (K Units) by Type (2020- 2031)
Figure 30. North America Transcutaneous Bilirubin Meters Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 31. North America Transcutaneous Bilirubin Meters Sales Volume (K Units) by Application (2020-2031)
Figure 32. North America Transcutaneous Bilirubin Meters Sales Revenue (US$ Million) by Application (2020-2031)
Figure 33. US Transcutaneous Bilirubin Meters Revenue (2020-2031) & (US$ Million)
Figure 34. Canada Transcutaneous Bilirubin Meters Revenue (2020-2031) & (US$ Million)
Figure 35. Mexico Transcutaneous Bilirubin Meters Revenue (2020-2031) & (US$ Million)
Figure 36. Europe Transcutaneous Bilirubin Meters Sales YoY (2020-2031) & (K Units)
Figure 37. Europe Transcutaneous Bilirubin Meters Revenue YoY (2020-2031) & (US$ Million)
Figure 38. Europe Top 5 Manufacturers Transcutaneous Bilirubin Meters Sales Revenue (US$ Million) in 2024
Figure 39. Europe Transcutaneous Bilirubin Meters Sales Volume (K Units) by Type (2020-2031)
Figure 40. Europe Transcutaneous Bilirubin Meters Sales Revenue (US$ Million) by Type (2020-2031)
Figure 41. Europe Transcutaneous Bilirubin Meters Sales Volume (K Units) by Application (2020-2031)
Figure 42. Europe Transcutaneous Bilirubin Meters Sales Revenue (US$ Million) by Application (2020-2031)
Figure 43. Germany Transcutaneous Bilirubin Meters Revenue (2020-2031) & (US$ Million)
Figure 44. France Transcutaneous Bilirubin Meters Revenue (2020-2031) & (US$ Million)
Figure 45. U.K. Transcutaneous Bilirubin Meters Revenue (2020-2031) & (US$ Million)
Figure 46. Italy Transcutaneous Bilirubin Meters Revenue (2020-2031) & (US$ Million)
Figure 47. Russia Transcutaneous Bilirubin Meters Revenue (2020-2031) & (US$ Million)
Figure 48. Asia-Pacific Transcutaneous Bilirubin Meters Sales YoY (2020-2031) & (K Units)
Figure 49. Asia-Pacific Transcutaneous Bilirubin Meters Revenue YoY (2020-2031) & (US$ Million)
Figure 50. Asia-Pacific Top 8 Manufacturers Transcutaneous Bilirubin Meters Sales Revenue (US$ Million) in 2024
Figure 51. Asia-Pacific Transcutaneous Bilirubin Meters Sales Volume (K Units) by Type (2020- 2031)
Figure 52. Asia-Pacific Transcutaneous Bilirubin Meters Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 53. Asia-Pacific Transcutaneous Bilirubin Meters Sales Volume (K Units) by Application (2020-2031)
Figure 54. Asia-Pacific Transcutaneous Bilirubin Meters Sales Revenue (US$ Million) by Application (2020-2031)
Figure 55. Indonesia Transcutaneous Bilirubin Meters Revenue (2020-2031) & (US$ Million)
Figure 56. Japan Transcutaneous Bilirubin Meters Revenue (2020-2031) & (US$ Million)
Figure 57. South Korea Transcutaneous Bilirubin Meters Revenue (2020-2031) & (US$ Million)
Figure 58. China Taiwan Transcutaneous Bilirubin Meters Revenue (2020-2031) & (US$ Million)
Figure 59. India Transcutaneous Bilirubin Meters Revenue (2020-2031) & (US$ Million)
Figure 60. Central and South America Transcutaneous Bilirubin Meters Sales YoY (2020-2031) & (K Units)
Figure 61. Central and South America Transcutaneous Bilirubin Meters Revenue YoY (2020-2031) & (US$ Million)
Figure 62. Central and South America Top 5 Manufacturers Transcutaneous Bilirubin Meters Sales Revenue (US$ Million) in 2024
Figure 63. Central and South America Transcutaneous Bilirubin Meters Sales Volume (K Units) by Type (2021-2031)
Figure 64. Central and South America Transcutaneous Bilirubin Meters Sales Revenue (US$ Million) by Type (2020-2031)
Figure 65. Central and South America Transcutaneous Bilirubin Meters Sales Volume (K Units) by Application (2020-2031)
Figure 66. Central and South America Transcutaneous Bilirubin Meters Sales Revenue (US$ Million) by Application (2020-2031)
Figure 67. Brazil Transcutaneous Bilirubin Meters Revenue (2020-2025) & (US$ Million)
Figure 68. Argentina Transcutaneous Bilirubin Meters Revenue (2020-2025) & (US$ Million)
Figure 69. Middle East, and Africa Transcutaneous Bilirubin Meters Sales YoY (2020-2031) & (K Units)
Figure 70. Middle East and Africa Transcutaneous Bilirubin Meters Revenue YoY (2020-2031) & (US$ Million)
Figure 71. Middle East and Africa Top 5 Manufacturers Transcutaneous Bilirubin Meters Sales Revenue (US$ Million) in 2024
Figure 72. Middle East and Africa Transcutaneous Bilirubin Meters Sales Volume (K Units) by Type (2021-2031)
Figure 73. South America Transcutaneous Bilirubin Meters Sales Revenue (US$ Million) by Type (2020-2031)
Figure 74. Middle East and Africa Transcutaneous Bilirubin Meters Sales Volume (K Units) by Application (2020-2031)
Figure 75. Middle East and Africa Transcutaneous Bilirubin Meters Sales Revenue (US$ Million) by Application (2020-2031)
Figure 76. GCC Countries Transcutaneous Bilirubin Meters Revenue (2020-2025) & (US$ Million)
Figure 77. Turkey Transcutaneous Bilirubin Meters Revenue (2020-2025) & (US$ Million)
Figure 78. Egypt Transcutaneous Bilirubin Meters Revenue (2020-2025) & (US$ Million)
Figure 79. South Africa Transcutaneous Bilirubin Meters Revenue (2020-2025) & (US$ Million)
Figure 80. Transcutaneous Bilirubin Meters Industry Chain Mapping
Figure 81. Regional Transcutaneous Bilirubin Meters Manufacturing Base Distribution (%)
Figure 82. Global Transcutaneous Bilirubin Meters Production Market Share by Region (2020-2031)
Figure 83. Transcutaneous Bilirubin Meters Production Process
Figure 84. Regional Transcutaneous Bilirubin Meters Production Cost Structure
Figure 85. Channels of Distribution (Direct Vs Distribution)
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What is the annual compound growth rate of the global Transcutaneous Bilirubin Meters market size from 2025 to 2031?
The annual compound growth rate of the global Transcutaneous Bilirubin Meters market is 2.8% 2025 to 2031.
Which companies rank high in the global Transcutaneous Bilirubin Meters market?
Which region is expected to have the highest market share?
What was the global market size of Transcutaneous Bilirubin Meters in 2025?
What was the global market size of Transcutaneous Bilirubin Meters in 2031?
Related Reports
Global Transcutaneous Bilirubin Meters Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Transcutaneous Bilirubin Meters market size was US$ 105 million in 2025 and is forecast to reach a readjusted size of US$ 113 million by 2032 with a CAGR of 1.3% during the forecast period 2026-2032.
Published Date: 2026-01-05
Pages: 99
USD 4250.00
(Single User License)
Global Transcutaneous Bilirubin Meters Market Research Report 2026
The global Transcutaneous Bilirubin Meters market was valued at US$ 105 million in 2025 and is anticipated to reach US$ 113 million by 2032, at a CAGR of 1.3% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 126
USD 2900.00
(Single User License)
Transcutaneous Bilirubin Meters- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Transcutaneous Bilirubin Meters was estimated to be worth US$ 105 million in 2025 and is projected to reach US$ 113 million, growing at a CAGR of 1.3% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 115
USD 3950.00
(Single User License)
Transcutaneous Bilirubin Meters - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Transcutaneous Bilirubin Meters was estimated to be worth US$ 107.05 million in 2024 and is forecast to a readjusted size of US$ 103.09 million by 2031 with a CAGR of -0.30% during the forecast period 2025-2031.
Published Date: 2025-12-01
Pages: 178
USD 3950.00
(Single User License)
Global Transcutaneous Bilirubin Meters Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Transcutaneous Bilirubin Meters market size was US$ 101 million in 2024 and is forecast to a readjusted size of US$ 122 million by 2031 with a CAGR of 2.8% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 102
USD 4250.00
(Single User License)
Transcutaneous Bilirubin Meters- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Transcutaneous Bilirubin Meters was estimated to be worth US$ 101 million in 2024 and is forecast to a readjusted size of US$ 122 million by 2031 with a CAGR of 2.8% during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 144
USD 3950.00
(Single User License)
Global Transcutaneous Bilirubin Meters Market Research Report 2025
The global market for Transcutaneous Bilirubin Meters was valued at US$ 101 million in the year 2024 and is projected to reach a revised size of US$ 122 million by 2031, growing at a CAGR of 2.8% during the forecast period.
Published Date: 2025-01-13
Pages: 103
USD 2900.00
(Single User License)
Global Transcutaneous Bilirubin Meters Market Insights, Forecast to 2030
A transcutaneous bilirubin meters is a device that measures the yellowish pigmentation of the skin and other mucous membranes caused by hyperbilirubinemia (increased levels of bilirubin in the blood). They are widely used in children's hospitals, baby care centers all over the world.
Published Date: 2024-04-28
Pages: 112
USD 4900.00
(Single User License)
Global Transcutaneous Bilirubin Meters Market Research Report 2024
A transcutaneous bilirubin meters is a device that measures the yellowish pigmentation of the skin and other mucous membranes caused by hyperbilirubinemia (increased levels of bilirubin in the blood). They are widely used in children's hospitals, baby care centers all over the world.
Published Date: 2024-02-05
Pages: 97
USD 2900.00
(Single User License)
Global Transcutaneous Bilirubin Meters Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Transcutaneous Bilirubin Meters market size was US$ 105 million in 2025 and is forecast to reach a readjusted size of US$ 113 million by 2032 with a CAGR of 1.3% during the forecast period 2026-2032.
Published: 2026-01-05
Pages: 99
USD 4250.00 (Single User License)Global Transcutaneous Bilirubin Meters Market Research Report 2026
The global Transcutaneous Bilirubin Meters market was valued at US$ 105 million in 2025 and is anticipated to reach US$ 113 million by 2032, at a CAGR of 1.3% from 2026 to 2032.
Published: 2026-01-05
Pages: 126
USD 2900.00 (Single User License)Transcutaneous Bilirubin Meters- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Transcutaneous Bilirubin Meters was estimated to be worth US$ 105 million in 2025 and is projected to reach US$ 113 million, growing at a CAGR of 1.3% from 2026 to 2032.
Published: 2026-01-05
Pages: 115
USD 3950.00 (Single User License)Transcutaneous Bilirubin Meters - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Transcutaneous Bilirubin Meters was estimated to be worth US$ 107.05 million in 2024 and is forecast to a readjusted size of US$ 103.09 million by 2031 with a CAGR of -0.30% during the forecast period 2025-2031.
Published: 2025-12-01
Pages: 178
USD 3950.00 (Single User License)Global Transcutaneous Bilirubin Meters Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Transcutaneous Bilirubin Meters market size was US$ 101 million in 2024 and is forecast to a readjusted size of US$ 122 million by 2031 with a CAGR of 2.8% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 102
USD 4250.00 (Single User License)Transcutaneous Bilirubin Meters- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Transcutaneous Bilirubin Meters was estimated to be worth US$ 101 million in 2024 and is forecast to a readjusted size of US$ 122 million by 2031 with a CAGR of 2.8% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 144
USD 3950.00 (Single User License)Global Transcutaneous Bilirubin Meters Market Research Report 2025
The global market for Transcutaneous Bilirubin Meters was valued at US$ 101 million in the year 2024 and is projected to reach a revised size of US$ 122 million by 2031, growing at a CAGR of 2.8% during the forecast period.
Published: 2025-01-13
Pages: 103
USD 2900.00 (Single User License)Global Transcutaneous Bilirubin Meters Market Insights, Forecast to 2030
A transcutaneous bilirubin meters is a device that measures the yellowish pigmentation of the skin and other mucous membranes caused by hyperbilirubinemia (increased levels of bilirubin in the blood). They are widely used in children's hospitals, baby care centers all over the world.
Published: 2024-04-28
Pages: 112
USD 4900.00 (Single User License)Global Transcutaneous Bilirubin Meters Market Research Report 2024
A transcutaneous bilirubin meters is a device that measures the yellowish pigmentation of the skin and other mucous membranes caused by hyperbilirubinemia (increased levels of bilirubin in the blood). They are widely used in children's hospitals, baby care centers all over the world.
Published: 2024-02-05
Pages: 97
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now